An atherothrombotic event is characterized by a sudden, unpredictable, atherosclerotic plaque disruption (rupture or erosion), and thrombus (blood clot) formation. It is the major cause of acute coronary syndromes and cardiovascular death. Atherothrombotic events can be reduced or prevented.
Drugs used to treat Prevention of Atherothrombotic Events
| Name | Drug Class |
|---|---|
| Vorapaxar | Protease-activated receptor-1 antagonists |
| Zontivity | Protease-activated receptor-1 antagonists |
